Corbus Announces Enrollment Completion of Dose Escalation Stage of Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC (Crb-701)
Corbus宣佈其下一代Nectin-4靶向ADC(Crb-701)的一期臨床試驗劑量遞增階段招募完成
Corbus Announces Enrollment Completion of Dose Escalation Stage of Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC (Crb-701)
Corbus宣佈其下一代Nectin-4靶向ADC(Crb-701)的一期臨床試驗劑量遞增階段招募完成
譯文內容由第三人軟體翻譯。